SBIR Challenge - HSE - Improving the Care of Patients - Gestational Diabetes & Diabetic Foot

The Challenge Background Diabetes is a serious global public health issue which has been described as the most challenging health problem in the 21st century. Between 1998 and 2015, there was a significant increase in the prevalence of doctor diagnosed diabetes among adults in Ireland (increasing from 2.2 % in 1998 to 5.2 % in 2015). The prevalence of undiagnosed diabetes in Ireland ranges from 0.9 – 2.8% of the population. People with diabetes are at serious risk of developing microvascular complications which can result in damage to feet, resulting in loss of sensation, damage to the back of the eye which can lead to blindness and damage to kidneys which can result in kidney failure. This small business Innovation Research (SBIR) competition specifically targets two key unmet needs: 1) Reducing the risk of women developing diabetes following gestational diabetes 2) Screening for diabetic foot disease in all patients with diabetes

Services

22/02/2019 18:00:00

73300000-5  Design and execution of research and development
73110000-6  Research services
73210000-7  Research consultancy services


Health Service Executive (HSE)
Head Office
Millennium Park
Naas
Ireland
View profile

Joe Heavey
http://www.hse.ie

Published notices
Contract notice (TED (v209)) 13/12/2018 17:10
Lots
Lot 1 - Reducing the Risk of Women Developing Gestational Diabetes Following Gestational Diabetes

This challenge seeks technology to underpin a comprehensive solution to reduce the proportion of women who progress from gestational diabetes (GDM) to Pre-Diabetes and Type 2 Diabetes within five years of the index pregnancy. (Please refer to tender documentation for more detailed information)

Additional information:
Documents Documents
Lot 2 - Screening for Diabetic Foot Disease in All Patients with Diabetes

This challenge seeks technology to underpin a comprehensive population-wide and community- based screening programme that would ensure that all patients with diabetes receive annual foot screening for risk factors for foot ulceration. Highly accurate screening tools (or technologies), that can detect early stage sensory loss and impaired circulation should form part of this solution. (Please refer to tender documentation for more detailed information)

Additional information:
Documents Documents
Close